Drug Shortage Report for SANDOZ LOSARTAN

Last updated on 2020-08-17 History
Report ID 111153
Drug Identification Number 02313340
Brand name SANDOZ LOSARTAN
Common or Proper name Losartan
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) LOSARTAN POTASSIUM
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-04-03
Estimated end date 2020-08-07
Actual end date 2020-08-07
Shortage status Resolved
Updated date 2020-08-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-04-06 English Compare
v2 2020-04-06 French Compare
v3 2020-05-04 English Compare
v4 2020-05-04 French Compare
v5 2020-05-11 English Compare
v6 2020-05-11 French Compare
v7 2020-06-08 English Compare
v8 2020-06-08 French Compare
v9 2020-06-29 English Compare
v10 2020-06-29 French Compare
v11 2020-07-06 English Compare
v12 2020-07-06 French Compare
v13 2020-08-17 English Compare
v14 2020-08-17 French Compare

Showing 1 to 14 of 14